J P Morgan Chase & Co lowered shares of Imperva (NASDAQ:IMPV) from a neutral rating to an underweight rating in a research note released on Tuesday morning, Marketbeat.com reports. The firm currently has $45.00 target price on the software maker’s stock.
Several other equities research analysts have also recently issued reports on IMPV. BidaskClub upgraded shares of Imperva from a sell rating to a hold rating in a report on Tuesday, August 22nd. Piper Jaffray Companies set a $58.00 target price on shares of Imperva and gave the stock a buy rating in a report on Monday, August 28th. Zacks Investment Research cut shares of Imperva from a strong-buy rating to a hold rating in a report on Wednesday, September 27th. Wells Fargo & Company cut shares of Imperva from an outperform rating to a market perform rating in a report on Monday, October 9th. Finally, William Blair cut shares of Imperva from an outperform rating to a market perform rating in a report on Tuesday, October 10th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. Imperva presently has a consensus rating of Hold and an average price target of $51.86.
Shares of Imperva (NASDAQ IMPV) opened at $41.05 on Tuesday. Imperva has a fifty-two week low of $37.05 and a fifty-two week high of $52.40.
A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. raised its position in Imperva by 4.3% in the second quarter. Vanguard Group Inc. now owns 2,439,240 shares of the software maker’s stock worth $116,718,000 after acquiring an additional 99,799 shares during the period. BlackRock Inc. raised its position in shares of Imperva by 11.3% during the 2nd quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock valued at $101,635,000 after purchasing an additional 215,170 shares during the period. Eagle Asset Management Inc. raised its position in shares of Imperva by 1.2% during the 3rd quarter. Eagle Asset Management Inc. now owns 1,294,651 shares of the software maker’s stock valued at $55,928,000 after purchasing an additional 14,803 shares during the period. Alyeska Investment Group L.P. raised its position in shares of Imperva by 89.3% during the 3rd quarter. Alyeska Investment Group L.P. now owns 907,615 shares of the software maker’s stock valued at $39,390,000 after purchasing an additional 428,163 shares during the period. Finally, ETF Managers Group LLC bought a new stake in shares of Imperva during the 2nd quarter valued at $41,888,000. Institutional investors and hedge funds own 96.95% of the company’s stock.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
What are top analysts saying about Imperva? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Imperva and related companies.